Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000950103-20-006219
Filing Date
2020-03-30
Accepted
2020-03-30 09:04:58
Documents
154
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F dp124295_20f.htm 20-F 1758714
2 EXHIBIT 4.18 dp124295_ex0418.htm EX-4.18 89356
3 EXHIBIT 12.1 dp124295_ex1201.htm EX-12.1 6857
4 EXHIBIT 12.2 dp124295_ex1202.htm EX-12.2 6854
5 EXHIBIT 13.1 dp124295_ex1301.htm EX-13.1 3432
6 EXHIBIT 13.2 dp124295_ex1302.htm EX-13.2 3588
7 EXHIBIT 15.1 dp124295_ex1501.htm EX-15.1 4166
8 EXHIBIT 15.2 dp124295_ex1502.htm EX-15.2 2367
15 GRAPHIC p050_fig01.jpg GRAPHIC 124516
16 GRAPHIC p051a.jpg GRAPHIC 59174
17 GRAPHIC p051b_fig02.jpg GRAPHIC 80493
18 GRAPHIC p053_fig03.jpg GRAPHIC 161753
19 GRAPHIC p054_fig04.jpg GRAPHIC 114963
20 GRAPHIC p055_fig05.jpg GRAPHIC 191236
21 GRAPHIC p056_fig06.jpg GRAPHIC 146182
22 GRAPHIC p057a.jpg GRAPHIC 82771
23 GRAPHIC p057b_fig07.jpg GRAPHIC 83524
24 GRAPHIC p059_fig08.jpg GRAPHIC 137096
25 GRAPHIC p060.jpg GRAPHIC 49171
26 GRAPHIC p061a_fig09.jpg GRAPHIC 93034
27 GRAPHIC p061b_fig10.jpg GRAPHIC 103407
28 GRAPHIC p062a_fig11.jpg GRAPHIC 90270
29 GRAPHIC p062b_fig12.jpg GRAPHIC 94531
30 GRAPHIC p064_fig13.jpg GRAPHIC 70065
31 GRAPHIC p065a_fig14.jpg GRAPHIC 82414
32 GRAPHIC p065b_fig15.jpg GRAPHIC 48177
33 GRAPHIC p069_fig16.jpg GRAPHIC 105322
34 GRAPHIC p070_fig17.jpg GRAPHIC 80577
35 GRAPHIC p071_fig18.jpg GRAPHIC 51382
36 GRAPHIC p072_fig19.jpg GRAPHIC 105229
37 GRAPHIC p073a_fig20.jpg GRAPHIC 116673
38 GRAPHIC p073b_fig21.jpg GRAPHIC 28675
39 GRAPHIC p075a_fig22.jpg GRAPHIC 76607
40 GRAPHIC p075b_fig23.jpg GRAPHIC 78407
41 GRAPHIC p076a_fig24.jpg GRAPHIC 72269
42 GRAPHIC p076b_fig25.jpg GRAPHIC 76741
43 GRAPHIC p077_fig26.jpg GRAPHIC 176859
44 GRAPHIC p078_fig27.jpg GRAPHIC 83385
45 GRAPHIC p079a_fig28.jpg GRAPHIC 63002
46 GRAPHIC p079b_fig29.jpg GRAPHIC 111260
47 GRAPHIC p080a_fig30.jpg GRAPHIC 24643
48 GRAPHIC p080b_fig31.jpg GRAPHIC 141192
49 GRAPHIC p081_fig32.jpg GRAPHIC 44283
50 GRAPHIC p082a_fig33.jpg GRAPHIC 151462
51 GRAPHIC p082b_fig34.jpg GRAPHIC 74829
52 GRAPHIC p083a_fig35.jpg GRAPHIC 112896
53 GRAPHIC p083b_fig36.jpg GRAPHIC 69490
54 GRAPHIC p084_fig37.jpg GRAPHIC 80396
55 GRAPHIC p085_fig38.jpg GRAPHIC 76580
56 GRAPHIC p086a_fig39.jpg GRAPHIC 115294
57 GRAPHIC p086b_fig40.jpg GRAPHIC 123974
  Complete submission text file 0000950103-20-006219.txt   16199651

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE aciu-20191231.xsd EX-101.SCH 110240
10 XBRL PRESENTATION FILE aciu-20191231_pre.xml EX-101.PRE 725252
11 XBRL LABEL FILE aciu-20191231_lab.xml EX-101.LAB 1242737
12 XBRL DEFINITION FILE aciu-20191231_def.xml EX-101.DEF 510002
13 XBRL CALCULATION FILE aciu-20191231_cal.xml EX-101.CAL 77294
14 XBRL INSTANCE FILE aciu-20191231.xml EX-101.INS 2273325
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-37891 | Film No.: 20754303
SIC: 2834 Pharmaceutical Preparations